News

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

Mapping techniques for tracking sexually transmitted bacterial disease can also identify core areas of HCV infection to guide treatment interventions.

A team of clinicians and investigators are working to define core outcome sets that it hopes will increase the utility of randomized clinical trials and stimulate research.

The FDA has approved cabozantinib (Cabometyx) for the treatment of patients with hepatocellular carcinoma who previously received sorafenib (Nexavar).

The 2016-2017 influenza season, dominated by the H3N2 strain, saw an uptick in the number of children experiencing neurological manifestations of influenza.

Study finds having a vaccinated child in the household was associated with 21% lower prevalence of sick leave usage by household adults.

Differing therapies, inaccurate regimens, missed diagnoses—issues can compound quickly for patients with PD seeking care for something else.

About half of all patients with COPD suffer from serious adverse events following a hospital discharge, yet physicians cannot accurately distinguish which are at risk.

The repeated dose vaccine from Sanofi Pasteur was assessed in 1300-plus patients aged 18 to 64. Currently, about 75% of US adults have not received a Tdap vaccination.

The imaging platform is now the only of its kind approved for optimizing blood clot removal in the US.

A recent study found a link between electronic nicotine delivery systems and asthma symptoms.

The Amplatzer Piccolo Occluder is implanted via catheter to repair patent ductus arteriosus in newborns weighing as little as 2 pounds.

Some of the most common symptoms of COPD drive anxiety in its patients. An England-based study sought out a cost-effective response.

People in high-risk categories should be tested and begin antiviral treatment promptly if they are hospitalized with flu symptoms, the Infectious Diseases Society of America recommends.

New research finds participants don’t always accurately report—or know—their HIV status when enrolling in studies.

Why it's critical for physicians to remember that patients may not be as well-versed on the particularities of conceiving a child.

The new C difficile guidelines highlight improvements in diagnosing the condition and treating with newer options like fidaxomicin, vancomycin, and fecal microbiota transplantation.

Flibanserin, a once-daily oral drug, is the only marketed therapy for female sexual dysfunction. Are more options needed?

At 10%, recurrence was lower in this analysis compared to other pediatric studies.

Lung cancer is currently the deadliest cancer in the US. An online guide and tool provider for physicians could help cut the rate.

A new study finds that age, gender, physician gender, income, and social behavior influence whether teenagers and young adults are confidential with their care providers.

A pilot study testing a multi-tasking game in children with autism and ADHD demonstrated feasibility, acceptability, and non-significant efficacy.

The 1100-patient study is comparing once-daily ponesimod and teriflunomide for patients with the relapsing form of the disease.

Dipanjan Basu, PhD, is testing non-melanoma drugs, like the investigational therapy omipalisib (GSK2126458) in cultured patient cells.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

The rate of palliative care in MS patients to have died in the hospital increased from 7.7% to 58.8% over 10 years ending in 2014.

The rate of youths using flavored tobacco products increased by nearly 7% from 2016 to 2017.